Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Dyer

Showing results (551-560 of 610) with videos related to

Pageof 61
Sort By:
Haematologica|October 20, 2018
DNA methylation profiling of hepatosplenic T-cell lymphomaAnke K Bergmann, Virginie Fataccioli, Giancarlo Castellano, et al.
Leukemia|December 17, 2020
Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphomaFranck Morschhauser, Martin J S Dyer, Harriet S Walter, et al.
British Journal of Haematology|April 1, 2015
Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patientsAnders Österborg, William G Wierda, Jiří Mayer, et al.
British Journal of Cancer|September 8, 2012
The collagen prolyl hydroxylases are novel transcriptionally silenced genes in lymphomaE Hatzimichael, C Lo Nigro, L Lattanzio, et al.
British Journal of Haematology|July 24, 2012
High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphomaVicente Fresquet, Eloy F Robles, Anton Parker, et al.
Chest|June 25, 2023
Emotional Distress, Anxiety, and General Health Status in Patients With Newly Identified Small Pulmonary Nodules: Results From the Watch the Spot TrialMichael K Gould, Beth Creekmur, Lihong Qi, et al.
Journal of Clinical Microbiology|October 10, 2014
Name changes in medically important fungi and their implications for clinical practiceG Sybren de Hoog, Vishnu Chaturvedi, David W Denning, et al.
Plos One|November 27, 2013
Prdm6 is essential for cardiovascular development in vivoAndreas Gewies, Mercedes Castineiras-Vilarino, Uta Ferch, et al.
Blood|November 7, 2015
A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignanciesHarriet S Walter, Simon A Rule, Martin J S Dyer, et al.
Angewandte Chemie (International Ed. in English)|March 6, 2024
Accessing Mg-Ion Storage in V<sub>2</sub>PS<sub>10</sub> via Combined Cationic-Anionic Redox with Selective Bond CleavageMatthew A Wright, T Wesley Surta, Jae A Evans, et al.
Pageof 61

Showing results (551-560 of 610) with videos related to

Sort By:
Pageof 61
Haematologica|October 20, 2018
DNA methylation profiling of hepatosplenic T-cell lymphomaAnke K Bergmann, Virginie Fataccioli, Giancarlo Castellano, et al.
Leukemia|December 17, 2020
Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphomaFranck Morschhauser, Martin J S Dyer, Harriet S Walter, et al.
British Journal of Haematology|April 1, 2015
Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patientsAnders Österborg, William G Wierda, Jiří Mayer, et al.
British Journal of Cancer|September 8, 2012
The collagen prolyl hydroxylases are novel transcriptionally silenced genes in lymphomaE Hatzimichael, C Lo Nigro, L Lattanzio, et al.
British Journal of Haematology|July 24, 2012
High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphomaVicente Fresquet, Eloy F Robles, Anton Parker, et al.
Chest|June 25, 2023
Emotional Distress, Anxiety, and General Health Status in Patients With Newly Identified Small Pulmonary Nodules: Results From the Watch the Spot TrialMichael K Gould, Beth Creekmur, Lihong Qi, et al.
Journal of Clinical Microbiology|October 10, 2014
Name changes in medically important fungi and their implications for clinical practiceG Sybren de Hoog, Vishnu Chaturvedi, David W Denning, et al.
Plos One|November 27, 2013
Prdm6 is essential for cardiovascular development in vivoAndreas Gewies, Mercedes Castineiras-Vilarino, Uta Ferch, et al.
Blood|November 7, 2015
A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignanciesHarriet S Walter, Simon A Rule, Martin J S Dyer, et al.
Angewandte Chemie (International Ed. in English)|March 6, 2024
Accessing Mg-Ion Storage in V<sub>2</sub>PS<sub>10</sub> via Combined Cationic-Anionic Redox with Selective Bond CleavageMatthew A Wright, T Wesley Surta, Jae A Evans, et al.
Pageof 61